Beigene Ltd ADR (NQ: BGNE )
192.50
-2.15
(-1.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Headline News about Beigene Ltd ADR![]() ![]() Via Benzinga
![]() ![]()
Evaluating BeiGene: Insights From 6 Financial Analysts
April 24, 2024
Via Benzinga
![]()
4 Analysts Assess BeiGene: What You Need To Know
March 27, 2024
Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Talk Markets
![]() ![]() ![]() ![]() ![]()
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.